Literature DB >> 3551634

Sympathetic function in spontaneously hypertensive rats after chronic administration of captopril.

K H Berecek, K A Kirk, S Nagahama, S Oparil.   

Abstract

The cardiovascular effects of electrical stimulation of the posterior hypothalamus, intravenous administration of norepinephrine (NE), and direct sympathetic nerve stimulation (SNS) were compared in spontaneously hypertensive (SHR) and Wistar-Kyoto rats (WKY) given captopril (osmotic minipump, 1.25 micrograms/h icv) or vehicle for 4 wk beginning at age 7 wk. Mean arterial pressure (MAP) and renal and mesenteric flows (pulsed Doppler flow probes) were monitored in anesthetized rats. Following chronic administration of captopril the MAP was 141 +/- 4 mmHg in SHR receiving captopril and 183 +/- 6 mmHg in SHR receiving vehicle. Posterior hypothalamic stimulation, intravenous NE, and SNS resulted in lesser increases in MAP and renal and mesenteric vascular resistances in SHR treated with captopril. Response curves were shifted to the right, and the initial slopes and rate of change of slopes of the curves were less in captopril-treated SHR than vehicle-treated rats. The decrease in sensitivity to posterior hypothalamic stimulation was greater than the decrease in response to NE or SNS. The decrease in vascular reactivity in captopril-treated SHR was not due to increased sensitivity of the baroreflex for control of vascular resistance nor to a decrease in arterial pressure per se. WKY treated with captopril also showed lesser increases in MAP and renal and mesenteric vascular resistances in response to posterior hypothalamic stimulation, intravenous NE, and SNS. The depressor effects of intracerebroventricular captopril in SHR may be due, in part, to an attenuation in sympathetic vasoconstrictor tone. This attenuation involves both a decrease in vascular smooth muscle responsiveness to NE as well as a decrease in central stimulation of sympathetic outflow.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3551634     DOI: 10.1152/ajpheart.1987.252.4.H796

Source DB:  PubMed          Journal:  Am J Physiol        ISSN: 0002-9513


  12 in total

1.  Prevention of renovascular and cardiac pathophysiological changes in hypertension by angiotensin II type 1 receptor antisense gene therapy.

Authors:  J R Martens; P Y Reaves; D Lu; M J Katovich; K H Berecek; S P Bishop; M K Raizada; C H Gelband
Journal:  Proc Natl Acad Sci U S A       Date:  1998-03-03       Impact factor: 11.205

2.  Losartan improved respiratory function and coenzyme Q content in brain mitochondria of young spontaneously hypertensive rats.

Authors:  Z Sumbalová; J Kucharská; F Kristek
Journal:  Cell Mol Neurobiol       Date:  2010-02-10       Impact factor: 5.046

3.  Aminopeptidase A inhibitors as potential central antihypertensive agents.

Authors:  A Reaux; M C Fournie-Zaluski; C David; S Zini; B P Roques; P Corvol; C Llorens-Cortes
Journal:  Proc Natl Acad Sci U S A       Date:  1999-11-09       Impact factor: 11.205

Review 4.  Sex and gender differences in control of blood pressure.

Authors:  Rodrigo Maranon; Jane F Reckelhoff
Journal:  Clin Sci (Lond)       Date:  2013-10       Impact factor: 6.124

5.  The contribution of brain angiotensin II to the baroreflex regulation of renal sympathetic nerve activity in conscious normotensive and hypertensive rats.

Authors:  Chunlong Huang; Misa Yoshimoto; Kenju Miki; Edward J Johns
Journal:  J Physiol       Date:  2006-05-11       Impact factor: 5.182

Review 6.  Brain renin-angiotensin system dysfunction in hypertension: recent advances and perspectives.

Authors:  Shereeni J Veerasingham; Mohan K Raizada
Journal:  Br J Pharmacol       Date:  2003-05       Impact factor: 8.739

7.  Effects of ACE inhibition on endurance exercise haemodynamics in trained subjects with mild hypertension.

Authors:  P Palatini; S Bongiovi; L Mario; P Mormino; G Raule; A C Pessina
Journal:  Eur J Clin Pharmacol       Date:  1995       Impact factor: 2.953

8.  Area-specific differences in transmitter release in central catecholaminergic neurons of spontaneously hypertensive rats.

Authors:  Anja G Teschemacher; Sheng Wang; Mohan K Raizada; Julian F R Paton; Sergey Kasparov
Journal:  Hypertension       Date:  2008-07-07       Impact factor: 10.190

9.  Effects of the converting enzyme inhibitor trandolapril on short-term variability of blood pressure in essential hypertension.

Authors:  C Dutrey-Dupagne; A Girard; A Ulmann; J L Elghozi
Journal:  Clin Auton Res       Date:  1991-12       Impact factor: 4.435

10.  Chronic control of high blood pressure in the spontaneously hypertensive rat by delivery of angiotensin type 1 receptor antisense.

Authors:  S N Iyer; D Lu; M J Katovich; M K Raizada
Journal:  Proc Natl Acad Sci U S A       Date:  1996-09-03       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.